Form 8-K - Current report:
SEC Accession No. 0001654954-21-007590
Filing Date
2021-07-02
Accepted
2021-07-02 17:06:33
Documents
1
Period of Report
2021-06-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT azrx8k06302021.htm 8-K 30127
  Complete submission text file 0001654954-21-007590.txt   31429
Mailing Address 1615 SOUTH CONGRESS AVENUE SUITE 103 DELRAY BEACH FL 33445
Business Address 1615 SOUTH CONGRESS AVENUE SUITE 103 DELRAY BEACH FL 33445 646-699-7855
AzurRx BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37853 | Film No.: 211071321
SIC: 2834 Pharmaceutical Preparations